This story is the ninth in ScienceInsider’s After Election 2014 series. Through Election Day on 4 November, we will periodically examine research issues that will face U.S. lawmakers when they return to Washington, D.C., for a lame-duck session and when a new Congress convenes in January. Click here to see all the stories published so far; click here for a list of published and planned stories.
Today, a look at the 21st Century Cures Initiative, which is expected to produce legislative proposals to improve biomedical research and innovation in the new Congress that convenes in January.
Can a congressional odd couple successfully shake up the complex system that transforms research discoveries into new drugs and treatments?
It’s a question that has been rippling through biomedical research circles in recent months, as an unlikely pair of allies—conservative Representative Fred Upton (R–MI) and the relatively liberal Representative Diana DeGette (D–CO)—have pursued a project they’ve dubbed the 21st Century Cures Initiative. The goal: to speed up the lengthy and costly process of developing new treatments for disease.